Surgical treatment of axillary hyperhidrosis with liposuction equipment: Risks and benefits

Acta Dermatovenerologica Croatica

Volumn 13, Issue 4, 2005, Pages 212-218

  Bieniek, Andrzej ^a   Białynicki Birula, Rafał ^a   Baran, Wojciech ^a   Kuniewska, Barbara ^a   Okulewicz Gojlik, Danuta ^a   Szepiełowski, Jacek C ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Axillary hyperhidrosis; Liposuction; Surgical treatment

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; AXILLA; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GENERAL ANESTHESIA; HEMATOMA; HUMAN; HYPERHIDROSIS; LIPOSUCTION; MALE; POSTOPERATIVE COMPLICATION; RECURRENT DISEASE; RISK BENEFIT ANALYSIS; SAFETY; SKIN DEFECT; SKIN FLAP; SKIN NECROSIS; SUBDERMAL SUCTION SWEAT GLAND CURETTAGE; SURGICAL APPROACH; SURGICAL TECHNIQUE; SWEAT GLAND; TREATMENT OUTCOME;

ADULT; AXILLA; CURETTAGE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERHIDROSIS; LIPECTOMY; MALE; PATIENT SATISFACTION; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 29944446337     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. In: Roenigk RK, Roenigk HH, editors. Dermatologic surgery, principles and practice. New York: Marcel Dekker; 1996. p. 623-45.
2. Harahap M. Management of hyperhidrosis axillaris. J Dermatol Surg Oncol 1979;5:223-5.
3. Holze E. Therapy of hyperhidrosis. Hautarzt 1984;35:7-15.
4. Ambroziak M, Kwiek B, Langner A. Leczenie nadmiernej potliwości. Dermatologia Estetyczna 2002;2:56-64.
5. Bushara KO, Park DM, Jones JC, Schutta HS. Botulinum toxin - a possible new treatment for axillary hyperhidrosis. Clin Exp J Dermatol 1996;21:276-8.
6. Carruthers A, Caruthers J. Botulinum A exotoxin. In: Marins RS, editor. Cosmetic surgery. New York: Marcel Dekker; 2001. p. 333-53.
7. Odderson IR. Hyperhidrosis treated by botulinum A exotoxin. Dermatol Surg 1998;24: 1237-41.
8. Schnider P, Binder M, Kittler H, Birner P, Starkel D, Wolff K, et al. A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis. Br J Dermatol 1999;140:677-80.
9. Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. BMJ 2001;323:596-9.
10. Naumann M, Lowe NJ, Kumar CR, Hamm H. Botulinum toxin type A is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study. Arch Dermatol 2003;139:731-6.
11. Salmanopoor R, Rahmanian MJ. Treatment of axillary hyperhidrosis with botulinum-A toxin, Int J Dermatol 2002;41:428-30.
12. Odderson IR. Long-term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis. Dermatol Surg 2002;28:480-3.
13. Hurley HJ, Shelley WB. A simple surgical approach to the management of axillary hyperidrosis. JAMA 1963;186:109-12.
14. Morgan BDG. Benign skin lesions. Congenital deformities of the neck. In: Barron JN, Saad MN, editors. Operative plastic and reconstructive surgery. New York: Churchill Livingstone; 1980. p. 557-79.
15. Landes E, Kappesser HJ. Surgical treatment of axillary hyperhidrosis. Fortschr Med 1979;97:2169-71.
16. Hasche E, Hagedorn M, Sattler G. Subcuteneous sweat gland suction curettage in tumescent local anesthesia in hyperhidrosis axillaris. Hautarzt 1997;48:817-9.
17. Lillis PJ. Tumescent anesthesia. In: Roenigk RK, Roenigk HH, editors. Dermatologic surgery, pinciples and practice. New York: Marcel Dekker; 1996. p. 41-52.
18. Klein JA. The pharmacology of tumescent liposuction. In: Narins RS, editor. Cosmetic surgery. New York: Marcel Dekker; 2001. p. 443-56.
19. Proebstle TM, Schneiders V, Knop J. Gravimetrically controlled efficacy of subcorial curettage: a prospective study for treatment of axillary hyperhidrosis. Dermatol Surg 2002;28:1022-66.
20. Field LM. Botox for a lifetime or tumescent axillary liposuction and curettage-once. Dermatol Surg 2003;29:317.
21. Field LM. Tumescent axillary liposuction and curettage with axillary scarring: not an important sequela. Dermatol Surg 2003;29:31.